These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 12116090)
21. Does octreotide prevent L-asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia? Tokimasa S; Yamato K Br J Haematol; 2012 May; 157(3):381-2. PubMed ID: 22145577 [No Abstract] [Full Text] [Related]
22. Platelet aggregation is stimulated by L-asparginase in children with acute lymphoblastic leukemia and normal individuals. Jaime-Perez JC; Gomez-Almaguer D Haematologica; 2002 Aug; 87(8):891-2. PubMed ID: 12161371 [No Abstract] [Full Text] [Related]
23. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia. Fadilah SA; Faridah I; Cheong SK Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167 [TBL] [Abstract][Full Text] [Related]
24. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic. Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511 [TBL] [Abstract][Full Text] [Related]
25. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases. Appel IM; Hop WC; Pieters R Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196 [TBL] [Abstract][Full Text] [Related]
27. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia. Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503 [No Abstract] [Full Text] [Related]
28. Acute bilateral parotitis during chemotherapy for acute lymphoblastic leukemia. Humphries JE; Lee JT Acta Haematol; 1992; 88(1):55-6. PubMed ID: 1384258 [No Abstract] [Full Text] [Related]
29. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia. Beinart G; Damon L Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293 [TBL] [Abstract][Full Text] [Related]
30. Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy. Saviola A; Luppi M; Potenza L; Morselli M; Bresciani P; Ferrari A; Riva G; Torelli G Eur J Haematol; 2004 Jan; 72(1):71-2. PubMed ID: 14962268 [TBL] [Abstract][Full Text] [Related]
31. [Acute pancreatitis secondary to L-asparaginase (a case report)]. Tazi I; Rachid M; Quessar A; Harif M; Benchekroun S East Mediterr Health J; 2009; 15(2):475-9. PubMed ID: 19554997 [No Abstract] [Full Text] [Related]
32. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683 [TBL] [Abstract][Full Text] [Related]
33. [Distal coronary thrombosis during L-asparaginase treatment for an acute lymphoblastic leukaemia]. Fraison JB; Calvet P; Domnisoru I; Altamiranda S; Vernhet-Kovacsik H; Saad A; Gallay P; Reny JL; Berdague P Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):303-5. PubMed ID: 21663890 [TBL] [Abstract][Full Text] [Related]
34. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study. Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537 [TBL] [Abstract][Full Text] [Related]
35. Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors. Al-Nawakil C; Willems L; Mauprivez C; Laffy B; Benm'rad M; Tamburini J; Fontaine H; Sogni P; Terris B; Bouscary D; Moachon L Leuk Lymphoma; 2014 Jul; 55(7):1670-4. PubMed ID: 24090500 [No Abstract] [Full Text] [Related]
36. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600 [TBL] [Abstract][Full Text] [Related]
37. [The adverse reaction of L-asparaginase and its prevention]. Lai YH; Wu ZL; Chen FX Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):533-4. PubMed ID: 16083559 [No Abstract] [Full Text] [Related]
38. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy. Salvador C; Meister B; Crazzolara R; Kropshofer G Pediatr Blood Cancer; 2012 Oct; 59(4):771. PubMed ID: 22619026 [No Abstract] [Full Text] [Related]
39. [Preliminary study on the safety and pharmacodynamic action of low dose L-asparaginase]. Wu ZL; Chen FX; Ye TZ; Lai YH; Cui YQ; Zou YW; Lu CY; Lan SL; Zhong GY; Guan JM; Wei FG; Zhang H Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):14-6. PubMed ID: 16732932 [TBL] [Abstract][Full Text] [Related]
40. [Feasibility and safety of chemotherapy for acute lymphoblastic leukemia in adolescents and young adults: Interim analysis of JALSG ALL202-U]. Kondo E Rinsho Ketsueki; 2012 Aug; 53(8):747-52. PubMed ID: 22975814 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]